As of the latest Form 4 filed Jun 15, 2026.
What Artivion Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 50 most recent filings for AORT.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | 2026-06-11 | GREEN ANDREW M SVP, Regulatory and Quality | SSale | −30.0K | $20.69 | $621K | Yes (planned) | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | GREEN ANDREW M, SVP, Regulatory and Quality | MExercise | +30.0K | $11.03 | $331K | Yes (planned) | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | GREEN ANDREW M, SVP, Regulatory and Quality | SSale | −14.0K | $20.71 | $290K | Yes (planned) | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | GREEN ANDREW M, SVP, Regulatory and Quality | MExercise | +14.0K | $18.44 | $258K | Yes (planned) | Form 4 ↗ |
| 2026-06-04 | 2026-06-02 | SEMEDO ANTHONY B. Director | JOther | +6.33K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-04 | 2026-06-02 | SEMEDO ANTHONY B., Director | JOther | −6.33K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-18 | SEMEDO ANTHONY B. Director | AAward | +7.58K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-18 | Salveson Jon W Director | AAward | +7.58K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-18 | Hoff Elizabeth A Director | AAward | +7.58K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-18 | Burbank Jeffrey H Director | AAward | +7.58K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-18 | Bullock James Director | AAward | +7.58K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-18 | BEVEVINO DANIEL J Director | AAward | +7.58K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-18 | ACKERMAN THOMAS F Director | AAward | +7.58K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-14 | Borgstrom Marna P Director | AAward | +7.85K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-04 | Holloway Jean F SVP, General Counsel | SSale | −8.96K | $38.00 | $341K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Horton Amy VP, Chief Accounting Officer | SSale | −901.00 | $37.78 | $34.0K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Holloway Jean F SVP, General Counsel | SSale | −3.84K | $37.78 | $145K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Stanton Marshall S. SVP, Clinical & MD Affair | SSale | −2.15K | $37.78 | $81.2K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Davis John E Chief Commercial Officer | SSale | −4.57K | $37.78 | $173K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Berry Lance A EVP, COO, CFO & Treasurer | SSale | −6.32K | $37.78 | $239K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Mackin James P President & CEO | SSale | −17.9K | $37.78 | $676K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Horton Amy VP, Chief Accounting Officer | AAward | +7.47K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Holloway Jean F SVP, General Counsel | AAward | +27.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Stanton Marshall S. SVP, Clinical & MD Affair | AAward | +21.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Davis John E Chief Commercial Officer | AAward | +28.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Berry Lance A EVP, COO, CFO & Treasurer | AAward | +40.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Mackin James P President & CEO | AAward | +117K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Horton Amy VP, Chief Accounting Officer | SSale | −641.00 | $38.02 | $24.4K | No | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Stanton Marshall S. SVP, Clinical & MD Affair | SSale | −1.51K | $38.02 | $57.5K | No | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Mackin James P President & CEO | SSale | −14.9K | $38.02 | $567K | No | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Holloway Jean F SVP, General Counsel | SSale | −2.18K | $38.02 | $83.0K | No | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Berry Lance A EVP, COO, CFO & Treasurer | SSale | −5.18K | $38.02 | $197K | No | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Davis John E Chief Commercial Officer | SSale | −2.78K | $38.02 | $106K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-24 | Horton Amy VP, Chief Accounting Officer | AAward | +5.66K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-24 | Horton Amy, VP, Chief Accounting Officer | SSale | −830.00 | $35.69 | $29.6K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-24 | Stanton Marshall S. SVP, Clinical & MD Affair | SSale | −1.26K | $35.69 | $44.9K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-24 | Holloway Jean F SVP, General Counsel | AAward | +20.1K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-24 | Holloway Jean F, SVP, General Counsel | SSale | −1.67K | $35.69 | $59.5K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-24 | Mackin James P President & CEO | AAward | +97.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-24 | Mackin James P, President & CEO | SSale | −13.9K | $35.69 | $497K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-24 | Berry Lance A EVP, COO, CFO & Treasurer | AAward | +37.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-24 | Berry Lance A, EVP, COO, CFO & Treasurer | SSale | −4.49K | $35.69 | $160K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-24 | Davis John E Chief Commercial Officer | AAward | +20.4K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-24 | Davis John E, Chief Commercial Officer | SSale | −2.08K | $35.69 | $74.1K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Horton Amy VP, Chief Accounting Officer | SSale | −1.73K | $37.59 | $65.1K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Stanton Marshall S. SVP, Clinical & MD Affair | SSale | −2.42K | $37.59 | $91.1K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Holloway Jean F SVP, General Counsel | SSale | −3.08K | $37.59 | $116K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Mackin James P President & CEO | SSale | −21.0K | $37.59 | $788K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Berry Lance A EVP, COO, CFO & Treasurer | SSale | −4.98K | $37.59 | $187K | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | Davis John E Chief Commercial Officer | SSale | −3.77K | $37.59 | $142K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also AORT’s full analysis or the market-wide insider trading feed. The tabs above jump to AORT’s other SEC data.
Source: SEC Form 4 filings for AORT, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.